Tag

Schedule III

19 articles tagged with "Schedule III"

All News Industry News35 Legislation347 Medical Cannabis18 Products15 Culture66 Science & Research16 Business115 International22

Business

Trulieve to Begin NYSE Trading June 2026 After Schedule III Move

Trulieve Cannabis will begin NYSE trading in June 2026 following federal rescheduling to Schedule III, becoming the first major cannabis operator to announce a Big Board listing.

Jun 9, 2026

Read

Medical Cannabis

ASA Releases Patient Rights Guide for Schedule III Cannabis

Americans for Safe Access published a patient rights guide explaining federal protections under proposed Schedule III reclassification. The resource addresses employment, healthcare, and legal questions for medical cannabis users.

Jun 6, 2026

Read

Legislation

Wyoming Blocks State Cannabis Rescheduling Despite Federal Move

Wyoming's top legal officer blocked automatic marijuana rescheduling under state law, preventing changes that would follow Trump's federal cannabis reclassification.

Jun 4, 2026

Read

Legislation

State Regulators Struggle to Guide Cannabis Businesses on Schedule III

State marijuana regulators say they can't advise licensed businesses on rescheduling impacts because federal agencies haven't issued guidance on tax relief, banking, or compliance requirements.

May 31, 2026

Read

Legislation

Three GOP Attorneys General Sue DOJ Over Cannabis Rescheduling

Republican attorneys general from Nebraska, Indiana, and Louisiana filed suit challenging the DOJ's cannabis rescheduling order, arguing it exceeds federal authority and conflicts with state prohibition laws.

May 30, 2026

Read

Legislation

Three GOP Attorneys General Sue DOJ Over Cannabis Rescheduling

Republican attorneys general from Indiana, Nebraska, and Louisiana filed a federal lawsuit challenging the Trump administration's cannabis rescheduling decision, arguing DOJ's action violated federal administrative law requirements.

May 28, 2026

Read

Legislation

DEA Rescheduling Hearing Draws Notices From Both Sides

Advocacy groups from both sides of the marijuana debate have filed notices to testify at DEA's February hearing on rescheduling cannabis to Schedule III, marking a critical juncture in federal policy.

May 27, 2026

Read

Legislation

TSA Updates Policy to Allow Medical Cannabis on Flights

TSA updated its screening policy April 27 to allow medical cannabis on domestic flights, following marijuana's Schedule III reclassification. The change creates new access for patients but leaves complex state law questions unresolved.

May 25, 2026

Read

Legislation

DOT Memo: Schedule III Move Doesn't Change Drug Testing for Drivers

A new USDOT memo confirms safety-sensitive transportation workers cannot use cannabis despite Schedule III rescheduling, with medical cards offering no protection from failed drug tests.

May 22, 2026

Read

Legislation

TSA Updates Medical Cannabis Policy—But Offers No Actual Guidance

TSA updated its website to list medical marijuana as permitted for air travel—but provided zero instructions on how patients can actually comply, leaving medical cannabis passengers in regulatory limbo.

May 19, 2026

Read

Legislation

DEA Expands Registration Forms to Cannabis Manufacturers and Labs

DEA will soon release federal registration forms for cannabis manufacturers, distributors, and testing labs, expanding beyond last month's dispensary-only registration as marijuana moves toward Schedule III reclassification.

May 12, 2026

Read

Legislation

Trump Drug Czar: Schedule III Won't Legalize Cannabis

ONDCP director Sara Carter Bailey told Newsmax that Schedule III rescheduling only covers medical use and research, emphasizing that marijuana "is still illegal" at the federal level.

May 12, 2026

Read

Legislation

SAM Files Federal Lawsuit Challenging DOJ Cannabis Rescheduling

Smart Approaches to Marijuana and a drug screening trade group filed a federal lawsuit challenging the Trump DOJ's decision to reschedule cannabis to Schedule III, using a law firm connected to a former Trump attorney general.

May 6, 2026

Read

Business

Big Pharma Eyes Cannabis as Schedule III Move Draws New Investment

Pharmaceutical companies and institutional investors are reassessing cannabis opportunities as federal rescheduling advances, potentially bringing new capital but also competition to the marijuana industry.

May 1, 2026

Read

Legislation

Cannabis Attorneys Clash Over Home Cultivation Under Schedule III

Four cannabis attorneys reached conflicting conclusions about whether rescheduling affects home cultivation, with some arguing licensed patients may qualify for Schedule III—but with federal obligations attached.

Apr 28, 2026

Read

Legislation

IRS to Issue Tax Guidance as Schedule III Takes Effect for Medical Cannabis

Treasury officials will issue new tax guidance following the Trump administration's order moving state-licensed medical marijuana to Schedule III, potentially ending 280E tax penalties for qualifying businesses.

Apr 24, 2026

Read

Legislation

Trump Publicly Pressures DOJ on Marijuana Rescheduling Delays

President Trump publicly questioned DOJ officials about marijuana rescheduling delays Saturday, four months after his executive order directing completion of the process.

Apr 19, 2026

Read

Legislation

DEA Faces Mounting Credibility Crisis as Cannabis Rescheduling Looms

The DEA's history of corruption cases and oversight failures is raising questions about its role in cannabis rescheduling decisions, even as the agency weighs a recommendation to move marijuana to Schedule III.

Apr 11, 2026

Read

International

Europe's Medical Cannabis Imports Surge as U.S. Rescheduling Looms

Germany's medical cannabis imports are surging as Europe builds pharmaceutical-based programs while U.S. operators await federal rescheduling decisions that may carry more symbolic than practical weight internationally.

Feb 25, 2026

Read